Pharma deals at 41st JP Morgan Healthcare conference

Against a backdrop of challenging circumstances around the globe in 2022, what do the pharma deals announced during the recent JP Morgan Healthcare conference suggest about investor sentiment and the way forward for pharma in 2023?